Gocovri User Reviews & Ratings
Gocovri has an average rating of 8.0 out of 10 from a total of 3 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Parkinson's Disease | 3 reviews for Parkinson's Disease | 55 medications |
- Suz...
- Taken for 1 to 6 months
- December 7, 2023
For Parkinson's Disease "Gocovri has reduced the length of time of my dyskinesia and reduced the severity as well. I am forced to go off of it due to the cost. Seems like the cost could be reduced to have more users. I can't afford $900 per month and then the donut hole! Back to Amantadine IR."
- Ano...
- Taken for 1 to 6 months
- September 9, 2025
For Parkinson's Disease "Well, it does seem to do what it’s supposed to do. It has given me, after six weeks of use, such vivid dreams and nightmares that it takes me a long time to fall back to sleep, so I think I’m either going to cut down to a 1/2 dose or switch back to the daytime version. I need to talk to my doctor."
Frequently asked questions
- What is the difference between Osmolex ER and Gocovri?
- What is Gocovri used to treat?
- Why should you not discontinue amantadine?
- How long does it take for amantadine to start working?
See also:
More about Gocovri (amantadine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
For Parkinson's Disease "Gocovri seemed to be better at controlling dyskinesia than Amantadine. There was less abdominal cramping in the morning. I was taking the 68.5 mg capsule, which is the lowest dose before bedtime. However, Gocovri is very expensive. My co-pay was close to $450 per month. I felt the difference in comparing the two medications' ability to control the dyskinesia was not sufficient enough to warrant the excessive cost of Gocovri."